• linkedin
  • Increase Font
  • Sharebar

    Guarded approval for new USPSTF PSA grade

    Grade D recommendation for men ≥70 years criticized


    AACU president discusses recommendation

    AACU President Charles A. McWilliams, MD, said the USPSTF’s recommendation incorporates many of the AACU’s longstanding positions and past comments that call for an individualized approach to screening based on an informed discussion between patients and doctors.

    He said the task force’s call for additional research on prostate cancer in African-American men “reinforces the need for individualized evaluation of the appropriateness of PSA-based screening based on factors specific to each patient.”

    Read - Telemedicine: Reimbursement in fee-for-service, quality models

    “These factors, of course, include age, and the AACU opposes the task force’s blanket recommendation against screening for men over the age of 70,” said Dr. McWilliams. “With life expectancy growing two-and-a-half years every decade, we believe select men over the age of 70 may benefit from prostate cancer screening.”

    The AACU also cautioned against associating PSA-based screening with potential harms of overtreatment, which USPSTF emphasized in its draft recommendations.

    “Continuing to tie potential complications with the awareness-raising test does not match up with the task force’s own acknowledgement that ‘[active] surveillance has become a more common treatment choice for men with lower risk prostate cancer over the past several years,’ ” he said.

    More from Urology Times:

    Survey: Majority of APPs perform advanced procedures

    Working with APPs: Try it, you’ll like it

    Value-based pay in 2017: Where does urology fit?

    Subscribe to Urology Times to get monthly news from the leading news source for urologists.

    Bob Gatty
    Bob Gatty, a former congressional aide, covers news from Washington for Urology Times.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results